SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-220705
Filing Date
2021-07-21
Accepted
2021-07-21 16:49:29
Documents
2
Group Members
ALAN FRAZIERBRIAN MORFITTFHM VII, L.L.C.FHM VII, L.P.FRAZIER HEALTHCARE VII-A, L.P.JAMES N. TOPPERNADER NAININATHAN EVERYPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SC 13D d298623dsc13d.htm SC 13D 252381
2 EX-99.A d298623dex99a.htm EX-99.A 14943
  Complete submission text file 0001193125-21-220705.txt   269130
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Healthcare VII, L.P. (Filed by) CIK: 0001553071 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650 325 5156
Imago BioSciences, Inc. (Subject) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1214
Type: SC 13D | Act: 34 | File No.: 005-92697 | Film No.: 211105056
SIC: 2834 Pharmaceutical Preparations